Loeys-Dietz Syndrome (LDS) is a rare genetic condition, caused by the inheritance of faulty genes through one or both parents (autosomal dominant).1 Affecting connective tissues, reduces the strength and flexibility of internal structures, including bones, ligaments, muscles, and blood vessels.2 The main challenge in diagnosing LDS is the wide variety of clinical symptoms. Often, patients can present with different concerns, and unfortunately, there are no set criteria for diagnosis.3
Among the most serious complications is vascular fragility. This describes the increased susceptibility of blood vessels to damage. To explain why this occurs, this article first examines the broader biological implications. In doing so, building the foundation needed to understand the molecular mechanisms.
Connective Tissue: Its Role in Blood Vessels
Complications arise in LDS through issues with connective tissue.4 Under normal situations this framework acts like an internal scaffold, providing strength and stability to the blood vessels.2
Connective tissue serves several important functions:
- Structural Support: To withstand blood pressure, blood vessels rely on the connective tissue proteins collagen and elastin.5 Collagen prevents the vessel from bursting, whilst elastin allows it to stretch and recoil
- Biological Functionality: They contain an extracellular matrix that regulates the movements of essential nutrients, cell signals for growth and repair, and immune cells travel.5 This makes sure proper function is maintained
- Anchoring and Protection: The outer layer of connective tissue helps anchor blood vessels to nearby structures and protects them from damage6
In patients with LDS, gene mutations directly affect the normal formation of connective tissue. These changes alter its properties and cause weak or disorganised tissues that can tear under blood pressure.2 This manifests clinically as vascular fragility.
Vascular Fragility: Impacts and Challenges
Unfortunately, detecting damage to blood vessels represents one of the most challenging aspects of LDS. Small tears don’t always lead to immediate problems and can remain unnoticed until they cause serious damage. Often these are missed without proactive and regular imaging,3 which are typically only performed when there is a cause for concern.
Common Signs Include
- Aortic Root Dilation: The aorta (main blood vessel which pumps blood from the heart) becomes enlarged at its root. This tends to begin in childhood and can progress quickly3
- Aortic Dissection: A serious tear in the wall of the aorta4 as a cause of root dilation and allowing blood to flow between the layers of the artery wall. This is often the first sign of the condition and can be fatal if left untreated
- Aneurysms: Ballooning and bulging in other arteries, including those in the neck, brain, abdomen, and legs2 which can rupture without warning
- Arterial Tortuosity: Arteries can become twisted or curved. The severity of symptoms depends on the extent of twisting, but it increases stress on the artery walls and may raise the risk of dissection2
Importantly for patients, the signs are progressive. This is because blood vessels are always under high pressure, and without intervention, existing damage can worsen until it leads to serious complications. The trigger for damage starts within the cell and involves a signal the body uses to communicate growth and repair,7 the TGF-β signalling pathway.
Molecular Causes: TGF-β Pathway
This pathway can be described as a cellular road, it transports a small molecule called TGF-β into the cells. This contains instructions that, once inside, tell the cell how to perform a variety of functions, especially important for maintaining healthy blood vessels.
These include:
- Growth and Repair: When a blood vessel is damaged TGF-β sends a signal to active repair mechanisms and replace damaged cells7
- Production of Elastin and Collagen: These structural proteins are the main components of connective tissue. Elastin gives tissues the ability to stretch and recoil (avoids pressure damage) and collagen provides structure. TGF-β controls the production and organisation of these proteins8
- Controlling Inflammation: Whilst a natural part of healing, if left uncontrolled inflammation can cause tissue damage. TGF-β controls the balance by regulating the immune response9
Gene Mutations: Disruption of the TGF-β Pathway
Like all systems in the body, the TGF-β pathway is carefully coordinated. This depends on a set group of proteins, each with different roles which work together to transport TGF-β into the cell. However, failure in any of these proteins prevents the cell from receiving the correct information. In LDS, gene mutations affect the structure and therefore function of these proteins causing dysregulation in the pathway.
There are currently 6 genes associated with LDS:
- TGFBR1 and TGFBR2: These form receptor proteins on the cell's surface and are the first to receive TGF-β,10 like antennae that only attract one specific thing
- SMAD2 and SMAD3: These form messenger proteins within the cell, acting like a shuttle to transport TGF-β to the most important part of the cell (the nucleus)4
- TGFB2 and TGFB3: These genes make TGF-β, this is the message itself11
Mutations across all the genes show a surprising and interesting pattern. Whilst directly reducing or blocking the action of the affected protein the system overcompensates by producing too much TGF-β.12 This throws the delicate system off balance and causes dysregulation of the pathway. This creates a harmful feedback loop where tissues try to repair but do so incorrectly and as a result further weaken the blood vessels.12,2
Treatment Options and Surveillance
The good news is several drugs can be used to help rebalance the system and control the abnormal TGF-β signalling. In turn, reducing the stress on blood vessels and either slowing down or preventing damage.
These Include:
- Angiotensin Receptor Blockers: These medications are commonly used to lower blood pressure. By blocking the angiotensin II (a hormone) that causes blood vessels to tighten, they help to relax the vessels, lower blood pressure, and reduce stress. Blocking hormone has also been shown to have a direct impact on the TGF-β pathway and may reduce the rate of aortic enlargement3
- Beta Blockers: These medications slow down the heart rate and reduce the force with which it beats. This reduces the physical strain on already vulnerable blood vessels3
- Statins and Anti-Inflammatory Drugs: These are being investigated as a way to reduce chronic inflammation which can worsen blood vessel damage with excess TGF-β signalling13
Preventative surgery to replace part of the aorta (the root) is also recommended before it reaches sizes normally considered dangerous.3 This reduces the chances of a potentially life-threatening tear. Repairing aneurysms in other vessels around the body, such as the brain or kidney requires careful planning due to tissue fragility.3
Ongoing care is essential for all patients with LDS. These may include but are not limited to annual heart scans (echocardiograms) and full body imaging of blood vessels via MRIs or CT angiography.3
Summary
Loeys-Dietz Syndrome is a progressive genetic disorder that usually goes unnoticed until serious damage is caused. Affecting connective tissue and the normal functioning of the TGF-β signalling pathway, the disease puts patients at risk of blood vessel damage (dilation, dissection, aneurysms, and tortuosity). Research has shown the molecular mechanisms to be underpinned by an upregulation of the TGF-β pathway, which causes damage to tissues over time. To manage the condition, lifelong monitoring is essential, helps detect changes, and guide effective treatment plans and decisions. As research continues, both existing and new treatments offer hope to manage risks effectively. If you or a family member are concerned about Loeys-Dietz Syndrome, speaking to a qualified genetic counsellor may be a good first step to helping you stay safe and informed.
References
- Loeys–Dietz Syndrome. In: eLS [Internet]. Chichester: Wiley; [cited 2025 Jun 6]. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/9781119432692.ch36
- MedlinePlus. Loeys-Dietz syndrome [Internet]. Bethesda (MD): National Library of Medicine (US); [cited 2025 Jun 6]. Available from: https://medlineplus.gov/genetics/condition/loeys-dietz-syndrome/
- National Center for Biotechnology Information. Loeys-Dietz syndrome [Internet]. Bethesda (MD): NCBI; 2006 [cited 2025 Jun 6]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1133/
- Zhai M, Ni Q, Li Z, Liang D, Liu Y, Wang J, et al. SMAD3 mutation in LDS3 causes bone fragility by impairing the TGF-β/SMAD3 pathway. Cell Biosci. 2022;12:125. doi:10.1186/s13578-022-00877-3
- National Center for Biotechnology Information. TGFBR2 gene [Internet]. Bethesda (MD): NCBI; [cited 2025 Jun 6]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538534/
- Elsevier. Tunica externa of vessel (vein) [Internet]. Elsevier; [cited 2025 Jun 6]. Available from: https://www.elsevier.com/resources/anatomy/blood-vessels/vein/tunica-externa-of-vessel-vein/15518
- Meng X, Zhang Y, Yu S, Chen Y, Zhang H, Hou J, et al. TGF-β signaling in health, disease, and therapeutics. Signal Transduct Target Ther. 2024;9:36. doi:10.1038/s41392-024-01764-w
- Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA. Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest. 1991;88(3):904–10. doi:10.1172/JCI115369
- Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, et al. Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome. Nat Genet. 2003;33(3):407–11. doi:10.1038/ng1116
- MedlinePlus. TGFBR2 gene: conditions [Internet]. Bethesda (MD): National Library of Medicine (US); [cited 2025 Jun 6]. Available from: https://medlineplus.gov/genetics/gene/tgfbr2/#conditions
- MacCarrick G, Black JH 3rd, Bowdin S, El-Hamamsy I, Frischmeyer-Guerrerio PA, Guerrerio AL, et al. Loeys–Dietz syndrome: a primer for diagnosis and management. Genet Med. 2014;16(8):576–87. doi:10.1038/gim.2014.11
- Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, et al. Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. J Clin Invest. 2011;121(1):183–91. doi:10.1172/JCI44628
- Prakash SK, Bouazzaoui A, Milewicz DM. Elastic fiber remodeling in aortic aneurysms caused by defects in the TGF-β pathway. Exp Cell Res. 2017;356(1):131–42. doi:10.1016/j.yexcr.2017.04.006

